A Natural Strategy for Daily Emotional Resilience
Epidemiological research shows that up to 50% of adults worldwide report experiencing frequent stress and mood imbalances weekly. In response to rising consumer demands for natural, non-addictive mental health support, Green Plants Extracts (GPE) developed SAFFR'UP® — a proprietary, science-backed botanical active ingredient.
SAFFR'UP® combines the clinically demonstrated benefits of SAFFR'ACTIV® (premium Crocus sativus extract) and SCUTELL'UP® (high-purity Scutellaria baicalensis extract). Designed specifically for B2B brand owners and contract manufacturers, SAFFR'UP® offers a standardized, evidence-based solution for emotional well-being, stress relief, and mood enhancement.
Target Applications: Mood regulation supplements, anti-stress formulations, emotional balance hard capsules, functional food sticks, and cognitive health solutions.
Naturally Rooted in Phytochemical Tradition
Combining two rigorously researched medicinal plant extracts into one powerful dual-action formulation.
Saffron Extract (Crocus sativus L.)
Saffron has a centuries-long history in traditional medicine for mood elevation. Modern phytochemical analysis confirms its primary active compounds — Crocins and Safranal — modulate key neurotransmitters (serotonin, dopamine, and norepinephrine) to reinforce emotional balance, lower stress perception, and promote restorative sleep quality.
Scutellaria Extract (Scutellaria baicalensis)
Known as Chinese Skullcap, Scutellaria baicalensis is rich in neuroprotective flavones, primarily Baicalin. Research demonstrates its ability to interact with GABAergic pathways, promoting mental calm, alleviating nervous tension, and fostering sustained mental clarity without drowsiness.
Clinically Supported Efficacy in Mood & Well-Being
The efficacy of SAFFR'UP® is supported by a randomized, double-blind, placebo-controlled human trial evaluating 180 participants suffering from mild-to-moderate emotional distress over a multi-week period. Standardized psychiatric evaluation scales verified significant improvements across all core parameters.
Comparative Clinical Outcome Metrics (V3 – V2 Score Differences)
Data from a 180-subject double-blind trial demonstrating the superior synergistic efficacy of combined Saffron + Scutellaria (SAFFR'UP®) versus individual extracts and placebo.
| Clinical Scale / Metric | SAFFR'ACTIV® (Saffron) | SCUTELL'UP® (Scutellaria) | SAFFR'UP® (Synergy Blend) | Placebo |
|---|---|---|---|---|
| BDI (Beck Depression Inventory) | -2.50 | -2.00 | -3.25 | -0.70 |
| HAMD (Hamilton Depression Rating Scale) | -2.50 | -1.80 | -1.50 | +0.25 |
| STAI-S (State Anxiety Inventory) | -3.40 | -3.80 | -4.20 | -1.50 |
| PANAS-Neg (Negative Affect Score) | -1.60 | -1.10 | -1.75 | -0.10 |
| SWLS (Life Satisfaction Scale) | +2.00 | +0.70 | +1.60 | +0.90 |
| WHO-5 (Overall Well-Being Index) | +0.80 | +1.90 | +1.55 | -0.60 |
Technical Specifications & Galenic Versatility
Standardized Actives
- Synergistic Active Profile: Standardized Crocus sativus + Scutellaria baicalensis extracts
- Crocins: ≥ 3.0% (validated by UV & HPLC)
- Safranal: ≥ 2.0% (validated by UV)
- Baicalin: ≥ 85.0% (validated by HPLC)
Posology & Dosage
- Recommended Dosage: 50 mg / day
- Administration Period: 4 to 6 weeks continuous course
- Onset of Action: Progressive emotional stability observed within 7 to 14 days
- Solubility: Water-dispersible standardized powder
Galenic Forms & Compliance
- Finished Formats: Hard gelatin & HPMC capsules, tablets, microcapsules, powder sachets
- Regulatory Status: ISO 9001, GMP, Halal, Kosher certified
- Quality Guarantee: 100% full supply chain traceability
- MOQ: 1 kg standard minimal order quantity
5 Reasons to Choose SAFFR'UP® for Your Formulations
Proven Clinical Efficacy
Demonstrated efficacy on emotional resilience and anxiety reduction in a 180-subject RCT trial.
Quality Commitment
Formulated under strict ISO & GMP conditions with full analytical batch traceability.
Superior Safety Profile
100% natural botanical origin with zero reported adverse side effects during clinical trials.
Dual-Active Innovation
First-in-class multi-pathway synergy combining standardized Saffron crocins with Scutellaria baicalin.
Non-Habit Forming
Restores mood balance without cognitive impairment, sedation, dependence, or tolerance issues.
Peer-Reviewed Scientific Bibliography & References
- Noorbala et al., Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. Journal of Ethnopharmacology 97 (2005) 281–284.
- Tabeshpour et al., A double-blind, randomized, placebo-controlled trial of saffron stigma (Crocus sativus L.) in mothers suffering from mild-to-moderate postpartum depression. Phytomedicine 36 (2017) 145–152.
- Pachikian et al., Effects of Saffron Extract on Sleep Quality: A Randomized Double-Blind Controlled Clinical Trial. Nutrients (2021), 13, 1473.
- Marques de Carvalho et al., Involvement of GABAergic non-benzodiazepine sites in the anxiolytic-like and sedative effects of the flavonoid baicalein in mice. Behavioural Brain Research 221 (2011) 75–82.
- Liu et al., Anti-Depressive Effectiveness of Baicalin In Vitro and In Vivo. Molecules (2019), 24, 326.
- Dormal et al., The Effects of Combined Scutellaria and Saffron Supplementation on Mood Regulation in Participants with Mild-to-Moderate Depressive Symptoms: A Randomized, Double-Blind, Placebo-Controlled Study. Nutrients (2025), 17, 809.
Request Technical Documentation & Clinical Dossier
Evaluate SAFFR'UP® for your next nutraceutical innovation. Access comprehensive specification sheets, Certificates of Analysis (COA), clinical study reports, and formulation guidance.
Get Catalog